MDxHealth SA
MDXH3.400USD
+0.250+7.94%
交易中 （美东）报价延迟15分钟
168.29M总市值
亏损市盈率 TTM
关于 MDxHealth SA 公司
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
MDxHealth SA简介
公司代码MDXH
公司名称MDxHealth SA
上市日期Jun 26, 2006
CEOMr. Michael K. McGarrity
员工数量312
证券类型Ordinary Share
年结日Jun 26
公司地址CAP Business Center
城市HERSTAL
上市交易所NASDAQ Capital Market Consolidated
国家Belgium
邮编4040
电话3243642070
网址https://mdxhealth.com/
公司代码MDXH
上市日期Jun 26, 2006
CEOMr. Michael K. McGarrity
MDxHealth SA公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Michael K. McGarrity
Mr. Michael K. McGarrity
Chief Executive Officer, Director
Chief Executive Officer, Director
95.00K
--
Mr. Michael Holder
Mr. Michael Holder
Director
Director
--
--
Mr. Mark Shaffar
Mr. Mark Shaffar
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Christopher (Chris) Thibodeau
Mr. Christopher (Chris) Thibodeau
Executive Vice President & U.S. Chief Operations Officer
Executive Vice President & U.S. Chief Operations Officer
--
--
Dr. Sanford S Siegel, M.D.
Dr. Sanford S Siegel, M.D.
Director
Director
--
--
Mr. Joseph (Joe) Sollee
Mr. Joseph (Joe) Sollee
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Mr. John Bellano
Mr. John Bellano
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Rudi Marien
Mr. Rudi Marien
Non-Executive Director
Non-Executive Director
--
--
Mme. Ruth Devenyns
Mme. Ruth Devenyns
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Walter M. (Wally) Narajowski
Mr. Walter M. (Wally) Narajowski
Non-Executive Independent Director
Non-Executive Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Michael K. McGarrity
Mr. Michael K. McGarrity
Chief Executive Officer, Director
Chief Executive Officer, Director
95.00K
--
Mr. Michael Holder
Mr. Michael Holder
Director
Director
--
--
Mr. Mark Shaffar
Mr. Mark Shaffar
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Christopher (Chris) Thibodeau
Mr. Christopher (Chris) Thibodeau
Executive Vice President & U.S. Chief Operations Officer
Executive Vice President & U.S. Chief Operations Officer
--
--
Dr. Sanford S Siegel, M.D.
Dr. Sanford S Siegel, M.D.
Director
Director
--
--
Mr. Joseph (Joe) Sollee
Mr. Joseph (Joe) Sollee
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2023
由于公司未披露，未能获取相关数据
地区USD
名称
营收
占比
United States of America
69.71M
99.31%
Europe
476.00K
0.68%
Rest of the world
9.00K
0.01%
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 12月12日 周五
更新时间: 12月12日 周五
持股股东
股东类型
持股股东
持股股东
占比
Bleichroeder LP
14.91%
AWM Investment Company, Inc.
10.55%
MVM Partners LLP
9.50%
Lytton (Laurence W)
6.36%
Genomic Health, Inc.
4.93%
其他
53.75%
持股股东
持股股东
占比
Bleichroeder LP
14.91%
AWM Investment Company, Inc.
10.55%
MVM Partners LLP
9.50%
Lytton (Laurence W)
6.36%
Genomic Health, Inc.
4.93%
其他
53.75%
股东类型
持股股东
占比
Investment Advisor
20.86%
Investment Advisor/Hedge Fund
14.93%
Venture Capital
9.52%
Individual Investor
6.67%
Corporation
4.93%
Hedge Fund
1.09%
Research Firm
0.12%
其他
41.87%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
49
21.80M
44.04%
-2.18M
2025Q2
45
28.07M
56.71%
+2.44K
2025Q1
47
29.82M
60.25%
-710.83K
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Bleichroeder LP
7.38M
14.91%
--
--
Jun 30, 2025
AWM Investment Company, Inc.
5.22M
10.55%
--
--
Jun 30, 2025
MVM Partners LLP
4.70M
9.5%
--
--
Jun 30, 2025
Lytton (Laurence W)
3.95M
7.98%
+1.06M
+36.63%
Dec 31, 2024
Genomic Health, Inc.
2.44M
4.93%
+1.50M
+159.38%
Sep 27, 2024
Samjo Capital, LLC
1.54M
3.1%
-96.72K
-5.93%
Jun 30, 2025
Perkins Capital Management, Inc.
1.42M
2.87%
+238.55K
+20.19%
Jun 30, 2025
Kennedy Capital Management LLC
47.80K
0.1%
+47.80K
--
Aug 31, 2025
Northern Trust Global Investments Limited
411.94K
0.83%
+3.93K
+0.96%
Jun 30, 2025
FreeGulliver LLC
123.55K
0.25%
+123.55K
--
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.04%
iShares Micro-Cap ETF
占比0.04%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
MDxHealth SA的前五大股东是谁？
MDxHealth SA 的前五大股东如下：
Bleichroeder LP持有股份：7.38M，占总股份比例：14.91%。
AWM Investment Company, Inc.持有股份：5.22M，占总股份比例：10.55%。
MVM Partners LLP持有股份：4.70M，占总股份比例：9.50%。
Lytton (Laurence W)持有股份：3.95M，占总股份比例：7.98%。
Genomic Health, Inc.持有股份：2.44M，占总股份比例：4.93%。
Bleichroeder LP持有股份：7.38M，占总股份比例：14.91%。
AWM Investment Company, Inc.持有股份：5.22M，占总股份比例：10.55%。
MVM Partners LLP持有股份：4.70M，占总股份比例：9.50%。
Lytton (Laurence W)持有股份：3.95M，占总股份比例：7.98%。
Genomic Health, Inc.持有股份：2.44M，占总股份比例：4.93%。
MDxHealth SA的前三大股东类型是什么？
MDxHealth SA 的前三大股东类型分别是：
Bleichroeder LP
AWM Investment Company, Inc.
MVM Partners LLP
Bleichroeder LP
AWM Investment Company, Inc.
MVM Partners LLP
有多少机构持有MDxHealth SA(MDXH)的股份？
截至2025Q3，共有49家机构持有MDxHealth SA的股份，合计持有的股份价值约为21.80M，占公司总股份的44.04%。与2025Q2相比，机构持股有所增加，增幅为-12.67%。
哪个业务部门对MDxHealth SA的收入贡献最大？
在FY2023，--业务部门对MDxHealth SA的收入贡献最大，创收--，占总收入的--%。
